{
  "name" : "dacemirror.sci-hub.se_journal-article_69f3e0fa778499f7c8b188e87bc003a3_zhao2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering",
    "authors" : [ "Hong Zhao", "Ruihua Ding", "Xin Zhao", "Yiwei Li", "Liangliang Qu", "Hao Pei", "Lara Yildirimer", "Zhengwei Wu", "Weixia Zhang", "John A. Paulson" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "Q1\nQ2\nQ3\nQ5\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS"
    }, {
      "heading" : "Graphene-based nanomaterials for",
      "text" : "drug and/or gene delivery, bioimaging, and tissue engineering Hong Zhao1,2,z, Ruihua Ding1,3,z, Xin Zhao4, Yiwei Li1,5, Liangliang Qu1, Hao Pei1, Lara Yildirimer6, Zhengwei Wu1,7 and Weixia Zhang1"
    }, {
      "heading" : "1 John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA",
      "text" : ""
    }, {
      "heading" : "2 Research Institute of Petroleum Processing, SINOPEC, Beijing 100083, China",
      "text" : "3Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA 4 Interdisciplinary Division of Biomedical Engineering, the Hong Kong Polytechnic University, Hung Hom, Hong Kong 5Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 6Barnet General Hospital Royal Free NHS Trust Hospital, Wellhouse Lane, Barnet EN5 3DJ, UK 7Department of Biomedical Engineering and Biotechnology, University of Massachusetts Lowell, Lowell, MA 01854, USA\nHere, we discuss the biomedical applications of graphene-based\nnanomaterials (GBNs). We examine graphene and its various derivatives,\nincluding graphene, graphene oxides (GOs), reduced graphene oxides\n(rGOs), graphene quantum dots (GQDs), and graphene composites, and\ndiscuss their unique properties related to their biomedical applications.\nWe also summarize the detailed biomedical applications of GBNs,\nincluding drug and/or gene delivery, bioimaging, and tissue engineering.\nWe also highlight the toxicity of these nanomaterials."
    }, {
      "heading" : "Introduction",
      "text" : "Since its unexpected discovery in 2004 [1,2], graphene has been propelled to the forefront of technological advancement with an almost infinite list of applications, for example, future electronics [3,4], energy or hydrogen storage [5,6], and biosensing [7,8], as result of its unique electronic, optical, thermal, and mechanical properties [9–12]. Graphene derives its properties from its chemical structure, which comprises a flat monolayer of carbon atoms packed into a 2D honeycomb lattice; this lattice is a basic building block for all other graphitic materials (Fig. 1).\nSuch versatility, combined with electronic flexibility [4,13], a large surface area [14], high mechanical strength [15], high intrinsic mobility [16,17], and unparalleled thermal conductivity [11], have rendered graphene and graphene-based materials attractive as technological tools. However, it was not until 2008 that graphene-based materials were first introduced into the field of biomedical sciences, when Dai et al. used graphene oxide (GO) as an efficient nanocarrier for drug delivery [18]. Since then, interest in its biomedical applications has gained momentum,\nHong Zhao received her BSc in chemical engineering from Sichuan University, Sichuan, in 2011 and her PhD from Tsinghua University, Beijing, China in 2016. She attended Harvard University as a visiting student under the supervision of David Weitz in 2014. Hong is currently an engineer in the Research Institute of Petroleum Processing (RIPP), Sinopec. Her research interests include nanocomposites, bioenergy, tracers, additives, and separation and purification processes.\nRuihua Ding received his BSc from the University of Wisconsin-Madison. He is currently a graduate student at Harvard University. His current research interests focus on the interface between biology and materials science, and on accessing and manipulating cell behaviors using nanomaterials and microstructures.\nWeixia Zhang received his MSc in chemistry from Tsinghua University in 2008 and his PhD in chemistry from Purdue University in 2014. Following his PhD, he joined the School of Engineering and Applied Sciences at Harvard University, where he is currently a postdoctoral research fellow. His research interests focus on organic synthesis, self-assembly, surface chemistry, the design and synthesis of various functional nanomaterials (including mesoporous materials; and carbon nanomaterials, such as graphene, and silicon nanowires), and biomedical applications of nanomaterials, and microfluidics.\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http:// dx.doi.org/10.1016/j.drudis.2017.04.002\nCorresponding author: Zhang, W. (wxzhang@seas.harvard.edu), (zhwx08@gmail.com) z These authors contributed equally to this article.\n1359-6446/ã 2017 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.drudis.2017.04.002 www.drugdiscoverytoday.com 1\nfr d b d li fi b a b t b a c d in r e\nR\nF\nG A\n2\nReview s K EY N O TE R EV IEW\nom drug and/or gene delivery, to bioimaging, and biomedical evices for tissue engineering. Given their ability to interact with iomolecules, such as DNA, and protect them from enzymatic egradation, as well as their capacity to act as delivery vehicles in ving cells and in vivo systems, graphene and its derivatives have rmly established themselves as next-generation candidates for iotechnological advancements. Therefore, here, we summarize nd critically appraise developments at the interface of grapheneased materials and biomedical science. We focus specifically on he impact of graphene on novel drug and/or gene delivery, ioimaging, and tissue engineering. Furthermore, we discuss the nticorrosion property of graphene in terms of using graphene oatings for biomedical implants and devices. Although we do not iscuss graphene synthesis or its chemical and physical properties,\n-depth information can be found elsewhere in several excellent\nimportant concerns regarding its biocompatibility and safety remain, and these are also discussed."
    }, {
      "heading" : "Graphene-based nanomaterials",
      "text" : "GBNs include graphene derivatives and graphene-based composites. Graphene derivatives, such as GO, rGO, GQDs, or nanoreduced graphene oxide (nano-rGO), can be obtained by using graphene or graphite as the starting material [22]. These are distinguished from each other in terms of their surface properties, number of layers, and size (Fig. 2).\nGO, an oxidation form of graphite, usually has single, bi- or multilayers of graphene sheets with epoxide, hydroxyl, and carboxylic acid groups [23]. GO is commonly synthesized using the Hummers method or derivatives thereof [24,25], which involves oxidation of graphite to various levels by using potassium per-\nEVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\nIGURE 1 raphene as a 2D building material for carbon materials of all other dimensionalities, including 0D bucky balls, rolled 1D nanotubes, or stacked 3D graphite. dapted, with permission, from Ref. [4].\neviews [3,13,19–21]. Despite the enthusiasm and reasons to be xcited about the role of graphene in the biomedical arena,\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\nwww.drugdiscoverytoday.com\nmanganate and sulfuric acid. GO contains a range of oxygen functional groups, mainly hydroxyl and epoxy groups on the basal\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nFIGURE 2 Schematic illustration of different graphene-based nanomaterials.\nplane, with smaller amounts of carboxyl, carbonyl, phenol, and lactone at the sheet edges [21,26–29]. The hydroxyl and epoxy groups form hydrogen bonds and weak interactions with other groups, whereas the carboxylic acid group offers negative surface charge and stability in polar solutions. Thus GO disperses well in water and other polar solvents [30]. In addition, GO is also amphiphilic, acting as a surfactant because of the hydrophobic properties of free surface p electrons from the unmodified graphene. More importantly, these reactive oxygen functional groups of GO enable researchers to conduct further chemical functionalizations to render GO an ideal platform for the accommodation of biomolecules, which is a key factor for its bio-related applications [26,31]. Even though the reactive oxygen functional groups increase the stability of graphene in solution as well as its chemical reactivity, the disrupted sp2 decreases its mechanical, electrical, and thermal properties [23].\nrGO is obtained by reducing GO to remove its oxygen functional groups [32]. Thermal and ultraviolet (UV) treatment of GO, or chemical treatment with hydrazine [33,34], ascorbic acid [35,36], sodium borohydride [37,38], hydroquinone [39,40] or other reducing agents [41–44] can restore the conjugated structure to form rGO. The recovered graphitic network of rGO results in a lower percolation threshold and fewer junctions, giving rise to its high electrical conductivity [45,46]. Although rGO has less oxygen\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\ncontent, surface charge, or hydrophilic functional groups compared with GO [23], it has been modified by noncovalent interactions, including p–p stacking and van der Waals interactions, to physically adsorb both polymers [47,48] and small molecules [49,50] onto its basal plane. Various studies have demonstrated that rGO is biocompatible, making it suitable for cell culture, biosensing, tissue engineering, and other biomedical applications [51–53].\nGQDs or nano-rGOs represent single layers or more (up to ten layers) of graphene or rGOs of a lateral size less than 30 nm [54– 56]. GQDs can be fabricated using both top-down and bottom-up approaches. Top-down approaches involve cutting large graphene sheets into ultrasmall GQDs using different physical, chemical, or electrochemical techniques, including hydrothermal process [57], chemical exfoliation [58], electrochemical oxidation [59], and electron beam lithography [60]. Bottom-up approaches refer to the synthesis of aromatic compounds as graphene moieties with a certain number of conjugated carbon atoms. Such approaches involve oxidative condensation reactions [61], pyrolysis [54,55], cage opening of fullerene [62], and nitration of pyrene [63]. As a result of strong quantum confinement and edge effects, GQDs show intense intrinsic photoluminescence, which can be further tuned by controlling their size, shape, defects, and functionalities [64–69]. Furthermore, compared with conventional semiconduc-\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nwww.drugdiscoverytoday.com 3\nt h t b d\ns – iz c s b d\nc fu a g fo n N N s t t p e s w d s o p\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\nT G\nG\nT\nrG\nG\n(2\nP\nP\nO\nG\nO G\nG\nN\n4\nReview s K EY N O TE R EV IEW\nor quantum dots, which suffer from high toxicity induced by the\neavy metals used, GQDs have many advantages, such as low\noxicity and excellent biocompatibility [70,71]. Thus, GQDs have een widely used in biosensing [72], cellular imaging [73], drug elivery, and photodynamic therapy [74,75].\nIn addition to the above graphene derivatives, based on the urface p electrons and functional groups, such as –COOH, COC–, and –OH, graphene-based materials can be functional-\ned with a large number of polymers, inorganic materials, and\nells through covalent or noncovalent interactions to obtain pecific properties or reduce their toxicity. Different grapheneased composites used commonly in biomedical applications are iscussed below.\nAs a result of the variety of the active functional groups of arboxylic acid, epoxy, and hydroxyl groups, GO can be widely\nnctionalized with organic materials to improve water stability nd reduce toxicity for biomedical applications. Polyethylene lycol (PEG) is one of the most used polymers to modify GO\nr good water stability and biocompatibility [76–78]. PEGylated\nano-graphene and GO are usually prepared by adding NH2-PEGH2, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and -hydroxysuccinimide (NHS) to stabilize the nano-GO (nGO)\nolution, followed by mixing at room temperature for 2 h and hen by centrifuging and washing [79]. Dextran has also been used o composite with nGO through p–p interactions to improve the hysiological stability for better drug delivery. For example, Jin t al. synthesized nGO-dextran-hematin hybrids by mixing a nGO olution with dextran-hematin in water followed by a reaction\nith ammonia and hydrazine solution [80]. The resulting nGOextran-hematin hybrids exhibited better colloidal stability in erum and cytocompatibility. In addition, 4-arm polypropylene xide (PPO)-polyethylene oxide (PEO)-tyramine (Tet-TA) [81], oly(vinyl alcohol) (PVA) [82], polyethylenimine (PEI) [83,84],\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\nABLE 1\nraphene-based nanocomposites and their fabrications as well as\nraphene-based nanocomposites Fabrication\nrimethyl chitosan/GO GO suspension mixed with folated co followed by sonication\nO-HA Hydroxyapatite microparticles suspen suspension followed by being vortex\nO-MSCs GO cultured in the supplemented DM followed by adding MSCs -dimethylamino)ethyl methacrylate (DMAEMA)-GO Surface-initiated ATRP of DMEAMA to AMAM-graphene Graphene alcohol suspension mixed conjugating PAMAM via EDC-couplin LA-PEG-grafted GQDs NH2-PEG-NH2 conjugated to the acti EDC-coupling followed by the 2nd ED rganosilane-GQDs Organosilane in ethanol mixed with ultrasonic condition O-polypeptide GO suspended in the PEG-PA aqueou changing temperature to form hydro ctaarginine-GO Activation of GO with NHS followed b O-Manganese Ferrite (MF) Oleylamine grafted GO mixed with M condition O-ZnS GO-PEG functionalized with reduced nanocrystals via an amidation reactio GO-PEG-Chlorin e6, NGO-branched polyethylenimine (BPEI)-Chlorin e6 Ce 6 conjugated to NGO-PEG or NGO\nwww.drugdiscoverytoday.com\nchitosan [85,86], and amphiphilic copolymers [87] have also been used to improve the stability.\nGraphene-based organic-inorganic hybrid materials are also widely used in the biomedical field for bioimaging, biosensing, and drug delivery. Solanki et al. encapsulated GO rich in oxygen groups on the surface of positively charged silica nanoparticles through electrostatic interaction [88]. The GO-Si hybrid NPs were obtained using GO nanosheet coating on the surface of silica NPs with diameter of 300 nm. Zhou et al. prepared GO/Au and GO/Ag composites in two steps. GO-CSH (cystamine dihydrochloride) were first prepared by adding CSH solution to the mixture of GO-COOH aqueous solution and MES solution with EDC followed by filtration and washing [89]. Then, the GO/Au and GO/Ag composites were obtained by mixing the prepared CO-CSH with noble metal NPs in water and stirred at 35 C for 24 h. Chen et al. prepared Fe2O3@Au core@shell NP–rGO nanocomposites for bioimaging [90]. Amino-functionalized PEGylated Fe2O3@Au NPs and carboxylated rGO were first prepared. Then, an amino-functionalized PEGylated Fe2O3@Au NPs solution was added to the mixture of rGO-COOH, EDC, sulfo-NHS, and MES buffer, followed by stirring for 1 h. After treatment with NaOH, ultrasonication, and centrifuging, rGO-Fe2O3@Au NP nanocomposites were obtained. Other inorganic materials, such as manganese ferrite [91], ZnS [92], and hydroxyapatite (HA) [93], have been widely used to composite with graphene-based nanomaterials for biomedical applications.\nOther graphene-based nanocomposites have also been prepared for improved biomedical applications. For example, graphene–cell biocomposites were prepared to extend the application of graphene-based nanomaterials beyond planar tissue cultures [94].\nOther graphene-based nanocomposites and their fabrications,\nas well as their applications, are detailed in Table 1.\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\napplications\nApplications Refs\nnjugated trimethyl chitosan DOX and gene delivery [86]\nsion mixed with rGO ed\nStimulating osteogenic differentiation of human MSC\n[93]\nEM medium overnight Enhanced chondrogenic differentiation\n[94]"
    }, {
      "heading" : "GO-SS-Br CPT delivery [195]",
      "text" : "with oleic acid followed by g reaction\nGene delivery [121]\nvated carboxyl GQDs via C coupling to conjugate PLA\nGene delivery and cell imaging [137]\nGO suspension under Cell imaging [138]\ns solution followed by gel composite\nAdipogenic differentiation of tonsil- derived MSCs\n[196]\ny reacting with octaarginine Gene delivery [197] F NPs under ultrasonic Hyperthermia agent [91]\nglutathione-coated ZnS n\nDrug delivery and cell labeling [92]\n-PEG-BPEI Photodynamic therapy [198]\nQ6\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W"
    }, {
      "heading" : "Properties of graphene-based nanomaterials",
      "text" : "Since being isolated in 2004, graphene has been intensively studied in terms of its fascinating properties. As a 2D material, graphene has a huge surface area that is approximately 2630 m2/g [14]. The strong C–C covalent bonds within the graphene sheet render it one of the hardest materials, with a Young’s modulus of 1100 GPa and a fracture strength of 130 GPa [15]. The p–p bonds below and above the atomic plane give graphene exceptional thermal and electrical conductivity. Single graphene has been reported to have a thermal conductivity of 5000 W/m/K [11]. The electrical conductivity of graphene has been reported to be 10000 S/cm [95], combined with ultra-high intrinsic mobility of 200 000 cm2v 1s 1 [16,17]. More details about graphene properties can be found elsewhere [96,97]. Here, we mainly emphasize properties of graphene-based materials that are closely related to their biomedical applications.\nThe first unique feature of graphene-based materials is their 2D planar structure with a high specific surface area; this enables them to be loaded or to interact with various chemical compounds and biological species. For graphene, the free p electrons at a high density on its planar surface make it suitable for electrophilic reactions with several organic molecules, such as click reactions, cycloadditions, and carbine insertion reactions [98]. Meanwhile, the conjugated basal plane enables graphene to interact with many drugs or other biomolecules containing aromatic structures via p–p stacking to fabricate biosensors [99]. The hydrophobic nature of graphene can also be used to absorb various hydrophobic organic molecules or polymers via van der Waals interaction [100]. In terms of GO, rGO, and other graphene derivatives, in addition to the above noncovalent p–p stacking and van der Waals interactions, the abundant oxygen functional groups on these derivatives provide more ways in which to immobilize molecules or biomolecules through both noncovalent interactions, including hydrogen bonds and ionic interactions, and covalent bonds via chemical reactions. Oxygen-containing groups, mainly ionic carboxylates and hydroxylates, can participate in ionic interactions or hydrogen bonding with the analogous ionic parts of biomolecules to facilitate the loading of the latter, which can be used for drug or gene delivery applications [101–103].\nThe astonishing mechanical properties of graphene have also inspired researchers to fabricate graphene-based composites with enhanced mechanical strength for various biomedical applications. Graphene, as a reinforcing filler, can improve the mechanical properties of many soft materials, such as hydrogels or polymer films [104], when forming graphene-based composites. After being oxidized, although the damaged structure leads to compromised mechanical properties of GO and other derivatives, both GO and rGO have been explored for enhancing the mechanical strength of polymeric materials, including PVA and poly (methyl methacrylate) [105]. These reinforced composites with increased modulus and hardness are suitable for tissue-engineering applications.\nGraphene and rGO have excellent electrical conductivity that can be utilized to fabricate electrical biomedical devices, including field-effect transistor biosensors, and to act as a substrate for conductive cell culture devices [106–108]. The low electrical conductivity of GO, which results from structure defects, limits the direct applications of GO in electrically active materials and\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\ndevice;, however, the oxygenated functional groups of GO can be used to immobilize various electroactive species through covalent or noncovalent bonds to fabricate sensitive electrochemical systems [26]. In addition, the good dispersibility of GO in many polar solvents, particularly water [21,30,109], makes it easy to process GO. The stable GO suspension can be deposited on electrodes to form thin conductive films that act as active electrode materials that can be used to detect or sense many biomolecules, including DNA, enzymes, and proteins [26].\nFinally, the optical properties of graphene-based materials are also useful for biomedical applications. Monolayer graphene has a light transmittance of 97.7% of the total incident light over a range of wavelengths [110]. Light absorption of graphene increases with its layer number [111]. When graphene size is reduced to the nanoscale to form nanoribbons, it can emit intrinsic photoluminescence because of band gaps that induced at this nanoscale. Similar properties are also observed in GO and GQDs, which enable researchers to apply these graphene-based materials for biomedical imaging [101,112]. In addition, GO has been demonstrated to be an efficient fluorescent quencher for a variety of fluorophores via nonradioactive electronic excitation energy transfer from the fluorophore to GO; this property has been exploited for biosensing, particularly as a fluorescence resonance energy transfer sensor, given its large adsorption cross-section [113–115]. Additionally, graphene and its derivatives have strong optical adsorption in the near-infrared range, making them powerful agents for photothermal therapy [116].\nBiomedical applications of graphene-based nanomaterials"
    }, {
      "heading" : "Drug delivery",
      "text" : "Over the past few years, motivated by the successes of carbon nanotubes in biomedicine, functionalized graphene has been explored in drug delivery. The advantages of graphene-based nanomaterials for drug delivery arise from their ability to cross cell membranes easily and their high specific surface area, which provides multiple attachment sites for drug targeting. Graphenebased nanomaterials can load drugs noncovalently via p–p stacking interactions, hydrogen bonding, or hydrophobic interactions.\nInitial studies using graphene-based nanomaterials for drug delivery were conducted by Dai et al. who loaded a camptothecin (CPT) analog, SN38 to GO-PEG via p–p stacking. The complex exhibited good water solubility, retaining a high efficiency of SN38 delivery, as well as high cytotoxicity in cells. Inspired by this pioneer work, many researchers have published studies exploring graphene-based materials for drug delivery. For instance, the same group reported the targeted delivery of rituxan using GO-PEG [101]. Jin et al. prepared hematin-conjugated dextran-functionalized GO hybrids via p–p interactions to deliver doxorubicin (DOX) for killing drug-resistant MCF-7/ADR cells [80]. Improved physiological stability was obtained and this hybrid had a loading capacity as high as 3.4 mg/mg nGO. The authors demonstrated that the release profile was pH dependent, with more released at lower pH; approximately 30% of the DOX was released over 6 days and the DOX-loaded hybrids accumulated effectively in the cytoplasm and nucleus to kill the cells (Fig. 3a). A similar pH-dependent DOX release profile was obtained when GO-PEG/ZnS:Mn composites were used as carriers (Fig. 3bi) [92]. DOX was loaded\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nwww.drugdiscoverytoday.com 5\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\nReview s K EY N O TE R EV IEW\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nTABLE 2\nOther drugs delivered using graphene-based nanomaterials"
    }, {
      "heading" : "Carriers Drugs Applications Refs",
      "text" : "nGO-PEG Cisplatin Inhibition of cell proliferation and morphology deformation [199] nGO-folic acid DOX and camptothecin delivery Targeted delivery of mixed anticancer drugs [103] PNIPAM-GS Camptothecin Temperature-dependent drug release with high CPT-loading efficiency [200] GO-PEG Ce6 photosensitizer Photodynamic therapy [122] Chitosan-GO Ibuprofen, 5-fluorouracil Controlled release of chemically diverse drugs [201] GN-CNT-Fe3O4 5-fluorouracil pH-dependent drug release [202] GO Hypocrellin Photodynamic therapy [203]\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\non the composite particles noncovalently and the loading capacity was dependent on the concentration of GO-PEG/ZnS:Mn, because more GO surface was available for DOX binding. When 1000 mg/ ml of a GO-PEG/ZnS:Mn solution was mixed with 300 mg/ml of a DOX solution, the loading capacity reached 100%. The DOXloaded composite particles killed approximately 85% of HeLa cancer cells (Fig. 3bii). To further control the drug release, PEGylated Fe2O3@Au core-shell NP-rGO nanocomposites were prepared to control the loaded DOX via synergistic interactions between photothermal therapy and chemotherapy [90]. The maximal DOX loading capacity was approximately 1.0 mg/mg nanocomposites via p–p stacking interactions. When the DOX-loaded composites were put in PBS of pH 7.4, 17% of DOX was released in 2 h, although a burst release occurred following irradiation under an 808-nm NIR laser. In addition, via magnetic field guidance, DOX– rGO–Fe2O3@Au NPs killed cells close to the magnetic field. Therefore, the loaded DOX could be released at specific sites and at a controlled rate. Zhou et al. also prepared graphene/Fe3O4composites using graphite oxide and FeCl3 6H2O as starting materials and used the composites to load DOX [117]. Given the the large specific surface area provided by graphene and the p–p interactions between graphene and DOX, a 65% loading capacity was obtained, which was higher than GO with the same Fe3O4. Meanwhile, the use of Fe3O4 NPs also led to better bioimaging because of the enhanced cell-to-background contrast [77].\nIn the delivery of paclitaxel (PTX), graphene-based nanomaterial-loaded PTX provided better cytotoxicity against cancer cells. Xu et al. functionalized GO with PEG to improve its stability in a physiological solution [118] and then loaded PTX onto the GO-PEG composites via p–p stacking and hydrophobic interactions, resulting in a relatively high loading capacity of 11.2 wt%. In a cellular uptake experiment, GO-PEG/PTX entered A549 and MCF-7 cells within 1 h. Compared with free PTX, GO-PEG/PTX of same amount led to lower cell viability, with an approximately 30% and 10% relative cell viability of A549 and MCF-7, respectively. Similar results were also obtained in Zhang and colleagues using PEGylated nGO to co-deliver PTX and indocyanine green (ICG) [79]. Low cytotoxicity was observed of nGO-PEG on MG-63 cells even at a concentration of 200 mg/m. Meanwhile, lower cell viability was obtained with nGO-PEG-ICG/PTX compared with free PTX (Fig. 3c).\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\ntreatment times. (iii) The cytotoxicity of different concentrations of free paclitaxel cells. (d) (i) Fluorescence microscopy images of NGO/PLA(7.8 K)–mPEG20 K comp FITC-labeled composites. PI was used to stain the nuclear and cytoplasmic nucleic a (ii) Cytotoxicity of blank NGO/PLA (7.8 K)-mPEG(20 K) composites, PTX-loaded NG Adapted, with permission, from [80] (a), [92] (b), [79] (c), and [119] (d).\nAngelopoulou et al. modified GO with poly(lactide)–poly(ethylene glycol) (PLA–PEG) copolymers for stability in an aqueous solution [119]. The PTX release profile was regulated by the molecular weight of PLA or PEG in the copolymer and their proportion in the composite, with a smaller molecular weight and larger proportion leading to faster release. The PTX-loaded composites demonstrated cytotoxicity against A549 cells with an increasing incubation time (Fig. 3d).\nOther drugs have also been delivered using graphene-based nanomaterials in addition to those described above, and selected examples are detailed in Table 2."
    }, {
      "heading" : "Gene delivery",
      "text" : "Gene therapy is a technique that uses genes to treat a genetic disease, and this approach has attracted intensive research attention. A key factor for gene therapy is to find efficient and safe gene vectors that protect DNA from nuclease degradation and facilitate its uptake with high transfection efficiency [23,120]. Graphenebased nanomaterials are appropriate candidates for gene delivery because of their high loading efficiency and increased gene transfection. To decrease their cytotoxicity and obtain cationic surface properties to allow their interaction with anionic oligonucleotides electrostatically, graphene derivatives have to be modified by polymers, such as chitosan [86], polyamidoamine (PAMAM) [121], polyethylenimine (PEI) [83], and so on. Zhang et al. reported using PEI-conjugated GO to sequentially deliver siRNA and DOX [122], exhibiting a synergistic effect that led to significantly improved therapy efficacy. Liu et al. explored using PEI-functionalized GO for gene delivery using different molecular weights of PEI [123], and showed significantly low cytotoxicity of the PEI-GO complex and successful use of GO as a novel nano-gene delivery vector with high transfection efficiency. Lactosylated chitosan oligosaccharide (LCO)-functionalized graphene oxides (GO-LCO) was prepared for the targeted delivery of DNA sequences to human hepatic carcinoma cells (QGY-7703) [85]. The loading capacity of FAM-DNA was as high as 4 mmol/g and it was delivered specifically to QGY-7703 within 0.5 h. In addition, no obvious toxicity was observed even at concentration of 100 mg/m. Hu et al. prepared folate-conjugated trimethyl chitosan (FTMC)/GO nanocomplexes (FG NCs) via electrostatic self-assembly to realize the targeted delivery of plasmid DNA (pDNA) [86].\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\n(PTX) and NGO-PEG–ICG/PTX (at the same concentration of PTX) on MG-63 osite uptake by A549 cells. Cells were incubated for different times (h) with cids red after incubation and overlay images are shown (magnification 20 x). O/PLA(7.8 K)-mPEG(20 K) composites, and PTX against A549 cancer cells.\nwww.drugdiscoverytoday.com 7\nC it N c r p g t d g w c w e g p b im T g p p\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\nF\nT R m\n8\nReview s K EY N O TE R EV IEW\nompared with A549 cells, Hela cells with folate receptors exhibed higher accumulation of FG NCs. The existence of FTMC in FG Cs could retard the migration of pDNA and facilitate pDNA ondensation. It was reported that 31.1% of pDNA could be eleased within 72 h in vitro in PBS, highlighting FG NCs as a romising candidate for gene delivery. Liu et al. synthesized raphene-oleate-PAMAM dendrimer hybrids via oleic acid adsorpion followed by covalent linkage of PAMAM dendrimers as gene elivery vectors [121]. The graphene-oleate-PAMAM exhibited ood dispersity in aqueous solutions and good biocompatibility\nith HeLa cells, but showed cytotoxicity to MG-63 cells at con-\nentrations >20 mg/ml. The graphene-oleate-PAMAM loaded\nith a quarter of pEGFP-N1 exhibited a GFP gene transfection\nfficiency of 18.3% to HeLa cells (Fig. 4ai,ii). PAMAM dendrimerrafted gadolinium-functionalized GO [124] and mPEGylated GO/ oly(2-dimethylaminoethyl methacrylate)(PDMAEMA) nanohyrids [125] were also synthesized for RNA delivery to obtain\nproved gene transfection efficiency and good biocompatibility. eimouri et al. prepared three different GO-based nanocarriers for ene delivery based on the conjugation of GO with cationic olymers of PEI, polypropylenimine (PPI), and PAMAM to comare their cytotoxicity and transfection efficiency [83]. GFP was\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\nIGURE 4\nitle. (a) GFP transfection efficiency of graphene-oleate-polyamidoamine (PAMAM NA-iPSC clones from hADFs were analyzed according to the expression of prot esoderm: brachyury, ectoderm: nestin, all shown in red) using immunocytoc\nwww.drugdiscoverytoday.com\nused to evaluate the transfection efficiency and the results showed that PEI-GO conjugate was ninefold more effective in the EGFPtransfected cells. Choi et al. also prepared GO-PEI complexes to effectively load mRNA for clinical applications [84] (Fig. 4b). After treatment with GO-PEI/RNA complexes, the cells increased their reprogramming efficiency and rat and human induced pluripotent stem cells (iPSCs) were generated successfully from adult adipose tissue-derived fibroblasts without repetitive daily transfection.\nIn addition to DNA, proteins can also be delivered using graphene-based materials for gene therapy. Zhang et al. reported the co-delivery of ribonuclease A and protein kinase A to the cell cytoplasm without enzymatic hydrolysis and loss of biological activity intracellularly, by loading proteins onto GO-PEG with a high payload via noncovalent interactions [126]. Hong and coworkers used multilayer GO-poly (b-amino ester) to entrap ovalbumin (OVA), a protein antigen [127], and demonstrated that the multilayer films blocked the initial burst release of OVA and could be precisely controlled to trigger its release upon the application of electrochemical potentials. Other examples include loading bone morphogenic protein-2 (BMP-2) to a GO-coated Ti substrate to enhance the differentiation of human mesenchymal stem cells (MSCs), which also showed robust new bone formation with this\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\n) to HeLa (i) and MG-63 (ii) cells. (b) In vitro differentiation potentials of GO-PEIein markers from each of the three germ layers (endoderm: alpha-fetoprotein, hemistry. Adapted, with permission, from [121] (a) and [84] (b).\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\nTi-GO-BMP2 implant, as demonstrated by Char et al. [128]; in addition, Geest and co-workers reported the intracellular protein vaccine delivery of GO-adsorbed proteins that could be efficiently internalized by dendritic cells and promoted antigen cross-presentation to CD8 T cells [129]."
    }, {
      "heading" : "Bioimaging",
      "text" : "Bioimaging has a crucial role in both research and clinical practice, and allows the observation and study of biological processes from the subcellular to small-animal level [130,131]. With the appropriate probe, bioimaging enables us to detect early-stage disease and to monitor the treatment response [130]. The versatile surface functionality of graphene-based materials for conjugating smallmolecular dyes, fluorescent NPs, or biomolecules, combined with their intrinsic luminescent properties, renders these materials ideal agents for bioimaging applications [131,132]. Here, we mainly focus on the optical imaging of graphene-based nanomaterials in biological applications.\nThe intrinsic photoluminescence of nGO can be used for fluorescence imaging, as first reported by Dai et al. These authors prepared PEG-GO covalently conjugated with the B cell-specific antibody rituxan (anti-CD20) (nGO–PEG–Rituxan) for Raji B celltargeted fluorescence imaging in the near-infrared region with little background [101]. However, the low quantum yield of nGOPEG fluorescence greatly limited the further in vivo fluorescent imaging of animals. To overcome this limitation, fluorescent dyes were used to functionalize GO either covalently or noncovalently to enhance the fluorescent signal for in vitro and in vivo imaging. For example, Liu et al. covalently labeled nGO-PEG with a Cy7 dye (nGO-PEG-Cy7) for in vivo fluorescent imaging of tumor-xenografted mice, showing ultrahigh tumor accumulation of nGOPEG-Cy7 based on the enhanced permeability and retention effect of cancerous tumors [133]. Chen et al. reported VEGF-loaded IR800-conjugated GO (GO-IR800-VEGF) for imaging ischemic muscle tissue in a murine hind limb ischemia model [134]. They demonstrated that the in vivo pharmacokinetics and biodistribution of GO-IR800-VEGF could be successfully monitored by NIR fluorescence imaging, indicating the potential of using GO in theranostic applications for treating ischemic disease. In addition to covalent functionalization, the direct loading of dyes or other photosensitizers was also investigated for fluorescence imaging. Chen et al. developed sinoporphyrin sodium (DVDMS)-loaded GO-PEG (GO-PEG-DVDMS) with improved fluorescent properties for enhanced optical imaging [135]. The fluorescent property of DVDMS was significantly enhanced because of the intramolecular charge transfer between DVDMS and GO-PEG, which enabled the use of GO-PEG-DVDMS for real-time fluorescent visualization of in vivo DVDMS delivery and distribution.\nIn addition to GO, GQDs with quantum confinement and edge effects have unique optical properties that can be used for bioimaging applications. GQDs have a wide optical absorption, from UV to near-infrared, with the strongest peak located in the UV region. The fluorescence color depends on the size of GQDs and GQDs with green and blue fluorescence have now been developed [56,112,136]. Zhu et al. used GQDs for conventional bioimaging by incubating human osteosarcoma cells with GQD suspensions [112]. The GQDs translocated into the cell via the cell membrane and were observed successfully, using a confocal fluorescence\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\nmicroscope. Cationic GQDs have a tendency to aggregate in aqueous solution, therefore, GQDs modified with biocompatible polymers are preferred. Dong et al. functionalized GQDs with poly (L-lactide) (PLA) and PEG for intracellular miRNA imaging analysis combined with gene delivery with improved therapeutic efficiency [137]. The PLA-PEG-grafted-GQDs exhibited excellent physiological stability and stable photoluminescence. PLA-PEG-graftedGQDs conjugated to agents targeting miRNA-21 and survivin, as a gene vector into Hela cells, were observed to fluoresce green inside cells under a confocal microscope, which enabled better observation and regulation of the gene delivery. Wen et al. fabricated fluorescent organosilane-functionalized GQDs (Si-GQDs) that were then embedded into mesoporous hollow silica nanospheres [138]. In the in vitro cellular uptake experiments in HePG2 cells, the hybrid nanospheres exhibited blue and green colors under excitation at 405 nm and 488 nm, respectively. The results showed functionalized GQDs to be promising candidates for bioimaging applications to help monitoring drug or gene delivery.\nIn addition to fluorescence imaging, Yang et al. recently reported a novel label-free highly sensitive imaging method for the fast visualization and quantitative layer analysis of graphene and GO, as well as real-time imaging of GO in vitro with cells and ex vivo in circulating blood, based on the transient absorption process [139]. They used megahertz modulation that effectively avoided the low-frequency laser noise and a resonant circuit that electronically amplified the heterodyne-detected signal. With this imaging platform, they achieved high-speed imaging of GO in living cells and animals with the capability of quantitative analysis of the intracellular concentration of well-dispersed PEG-GO (Fig. 5), opening new opportunities for using GO as a bioimaging agent based on the transient absorption imaging method.\nRaman spectra of graphene-based nanomaterials have also been applied for bioimaging. Both graphene and GO exhibit unique intrinsic Raman signals that can be further enhanced by integrating metal NPs [140–144]. Tan and Zhang et al. reported the facile synthesis of AgCu@graphene (ACG) NPs by growing several layers of graphene onto the surface of AgCu alloy NPs using the chemical vapor deposition method [140]. The ACG NPs have been utilized to enhance unique Raman signals from the graphitic shell, making ACG an ideal candidate for cell labeling, rapid Raman imaging, and surface-enhanced Raman spectroscopy (SERS) detection. In situ reduction of metal ions on GO results in stronger Raman signals from metal–GO hybrids compared with the pristine GO. Guo et al. developed GO-Ag NP composites by in situ reducing Ag+ using polyvinylpyrrolidone as a novel SERS label for fast cellular probing and imaging [141]. The authors demonstrated that, by utilizing GO-Ag NPs as a highly sensitive optical probe, fast SERS imaging of cancer cells was realized with a short integration time of approximately 0.06 s per pixel. Zhao and co-workers reported the one-step synthesis of nanosized GO-wrapped gold NPs [142]. These GO-Au nanocomposites could be utilized for both intracellular bioimaging tags and drug delivery carriers. Similar results were also reported by Liz-Marzan and co-workers [143]. Noncovalent attachment of Au NPs to GO via p–p stacking or other molecular interactions has also been used for Raman imaging. Zhang et al. reported that the presence of Au NPs on the GO sheet has an important role in the observation of enhanced Raman spectra of GO in live cells [144]. In addition to these optical\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nwww.drugdiscoverytoday.com 9\nim u in p e m n\nT T s o m e t t t c e t\nin o p s a r e t e t\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\nFIGURE 5 Title. (a) Dynamic cellular uptake of GO-PEG was monitored by TA imaging overtime, from 0 to 180 min after treatment. TA images (first row) and overlay images (second row) showed intracellular accumulation of GO-PEG (yellow dots). Scale bar = 10 mm. (b) Quantification of mean TA signal intensity per cell in GO-PEG treated cells from (a). (c) TA imaging of GO-PEG circulating in rat blood vessel. Scale bar = 20 mm. Adapted, with permission, from [139].\n1\nReview s K EY N O TE R EV IEW\naging methods, graphene-based nanomaterials have also been sed for other imaging modalities, including photoacoustic imag-\ng [145], magnetic resonance imaging [146], computed tomograhy [147], as well as radionuclide-based imaging, such as positron mission tomography and single-photon emission computed to-\nography [148,149]. However, due to the space constraints, we do\not discuss them in detail here.\nissue engineering issue engineering has emerged as a significant novel medical trategy to restore, maintain, or improve the function of a tissue r whole organ by using a combination of cells, engineering\naterials, and suitable biochemical factors [150]. A crucial paramter for tissue engineering is to develop suitable biomaterials hat can mimic the biological environment and provide surfaces o interface with living cells, enabling cell attachment, proliferaion, and differentiation. Given their ease of functionalization ombined with fascinating mechanical strength, stiffness, and lectrical conductivity, graphene-based materials have attracted remendous interest in the tissue-engineering field [151,152].\nOne application of graphene-based materials in tissue engineerg is as reinforcement materials in hydrogels, films, fibers, and ther tissue-engineering scaffolds, to enhance their mechanical roperties and stability by utilizing the mechanical strength and tiffness of graphene-based materials. Cerruti et al. prepared\n3D GO/HA hydrogel for bone tissue engineering [153]. The esulting highly porous hydrogel showed strong mechanical proprties, high electrical conductivity, and good cell compatibility o MSCs, making them excellent candidates for bone tissuengineering applications. GO nanosheets have also been shown o greatly improve the mechanical properties of poly(acrylic acid)\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\n0 www.drugdiscoverytoday.com\n(PAA)/gelatin hydrogels and chitosan hydrogel scaffolds [154,155]. Additionally, Ruoff and co-workers presented polyoxyethylene sorbitan laurate (TWEEN) and rGO hybrid films [156]. They demonstrated that the as-prepared hybrid films were mechanically robust, biocompatible with three different mammalian cell lines, and antimicrobial. Xie et al. prepared chitosan-poly (vinyl alcohol) nanofiber-containing graphene by using the electrospinning method [157]. They found that these reinforced fibers showed rapid wound healing in mice and rabbits because of the presence of free electrons in graphene inhibiting prokaryotic cell multiplication but without affecting the proliferation of eukaryotic cells.\nIn addition to mechanical enhancement, the electrical properties of graphene-based materials enable researchers to use them for specific tissue-engineering applications. Hong et al. reported that a graphene substrate promoted the adhesion and neural differentiation of human neural stem cells (hNSCs) [158]. The authors proposed that the mechanism of enhanced differentiation to neurons was electrical coupling between the hNSCs and the graphene. Cheng et al. demonstrated the promotion of neurite sprouting and outgrowth of mouse hippocampal cells on graphene substrates [159]. They speculated that the high electrical conductivity of graphene led to better neurite outgrowth, indicating that graphene could be used as an implant material or neural chip for tissue engineering in the nervous system. Similar results were also reported by Liu et al. [160]. Recently, Wang and co-workers reported a hybrid conducting system of poly(3,4-ethylenedioxythiophene) (PEDOT)-rGO microfibers [161]. These hybrid microfibers exhibited enhanced cell proliferation and improved neural differentiation of MSCs with electrical pulses induced by a selfpowered triboelectric nanogenerator. Loh et al. studied the culture\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\nof bone marrow-derived MSCs on graphene and GO substrates [162]. They found that the strong noncovalent binding abilities of graphene arising from p–p stacking, electrostatic, and hydrogen bonding allowed it to act as a preconcentration platform for osteogenic inducers, which accelerated the growth of MSCs toward the osteogenic lineage.\nIn addition to their mechanical and electrical properties, the surface functionalization of graphene-based materials is also useful for tissue-engineering applications. Gu et al. reported that aminefunctionalized GO showed superior cell viability and proliferation with excellent anticoagulation effects [163]. Estrada and co-workers reported the elongated structure of multinucleated myoblasts on laminin-coated graphene, indicating their differentiation into myotube cells [164]. GO has also been shown to help cells differentiate into skeletal muscle, likely because of their roughness and serum protein absorption [165]. It is also believed that absorbing fibronectin on a graphene-based material surface would promote articular cartilage regeneration [166]. GO has been found to help adipose tissue generation, the mechanism of which was attributed to absorption of insulin [162]. Additionally, Zeng et al. reported gelatin-functionalized GO (GO-Gel) for the biomimetic mineralization of HA [167]. They demonstrated that the GO-Gel promoted cell adhesion, proliferation, and osteogenic differentiation of\nMC3T3-E1 cells, indicating that GO-Gel could be used as osteogenesis-promoting scaffold for bone tissue engineering. Zeng and co-workers also reported similar results using GO functionalized with the polysaccharide carrageenan [168].\nIn addition, the chemical inertness and impermeability of graphene enable it to be used as a biocompatible anticorrosion coating for metallic biomedical devices. Rao et al. reported that graphene coating enhanced both the bio- and hemocompatibility of implant materials [169,170]. Yang and co-workers demonstrated the use of graphene as a protection film in biological environments [171]. They conducted both in vitro cellular experiments and in vivo animal experiments to demonstrate the effective protection of metal by graphene under biological conditions (Fig. 6). Their results highlight the potential of using graphene coatings to protect metal surfaces in biomedical applications, such as metal implants. Wei et al. reported that a GO/HA-coated Ti substrate also exhibited high corrosion resistance, with enhanced coating adhesion strength and superior cell viability [172]."
    }, {
      "heading" : "Toxicity of graphene-based nanomaterials",
      "text" : "So far, graphene-based materials have exhibited huge potential in numerous biomedical applications. To further expand their use and advance the translation of these applications from the lab to a\ne. (b) Relative cell viability of bone cells incubated with SLG/Cu, BLG/Cu, and\nof any form of Cu foil. (c) Concentration of Cu2+ ions in blood extracted from\ntrol (black square), rats with implanted SLG/Cu foils (blue triangles), and rats\nted, with permission, from [171].\nc is t u la r t g t g o b ic\nc [1 T a d d g\nd c w a e p w o A m fo 5 n 1 g r g\nn c c in s a e d w d\nR\n1\n2\n3\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\n1\nReview s K EY N O TE R EV IEW\nlinical setting, a deeper understanding of their potential toxicity\nrequired. Intense efforts have been devoted to elucidating the oxic effects of graphene and its derivatives. However, the molec-\nlar mechanism of the toxicity of graphene-based materials is still rgely unclear. For example, recent studies obtained contradictoy outcomes that observed both toxic and nontoxic effects simulaneously when evaluating the in vitro and in vivo toxicity of raphene [156,173,174]. Therefore, it is currently inappropriate o draw any generalized conclusions about the toxic effects of raphene-based materials, particularly when regarding the variety f different forms of graphene and methods of synthesis. Here, we riefly summarize and discuss the current state-of-the art of tox-\nity studies of graphene-based materials.\nGraphene and its related congeners have been reported to cause ell damage via inducing generations of reactive oxidant species\n60,175] and/or mutations during cell replication [176,177].\nheir toxicity has been demonstrated to be time [178,179], dose nd/or concentration [178,180], and characteristic [177] depenent. Cell–graphene interactions in vitro have been shown to epend on multiple parameters, including surface chemistry, raphene size and/or shape, and impurities.\nThe surface chemistry of graphene has an essential role in etermining its cytotoxicity. Generally, bare graphene or GO an interfere with the cell membrane via adhesion or bonding\nith cell receptors to block the supply of nutrients, induce stress,\nnd activate apoptotic mechanisms, resulting in high toxicity ven at low concentrations [181]. Functionalization of grahene-based materials with biocompatible polymers or molecules\nill greatly reduce cytotoxicity. Dai et al. showed that PEGylation f GO exhibited no cellular toxicity up to 100 mg/ml [18,101]. lexis and co-workers reported that graphene with PEG and PLA\nodification showed no dose-dependent toxicity up to 250 mg/ml r U138 cells, whereas hydroxylated graphene showed toxicity at 0 mg/ml in the same study [182]. Curley et al. found that sulfoated GO was nontoxic across the concentration range of 0.1– 0 mg/ml [183]. Additionally, carboxylation [184], dextran conjuation [185,186], and PEI [123] have also been demonstrated to educe graphene cytotoxicity, by increasing the hydrophilicity of raphene derivatives.\nIn addition to surface functionalization, the size of graphene anomaterials also affects their interaction with cells and their ytotoxicity. Wang et al. studied the in vitro toxicity of GO on A549 ells [180]. They reported that graphene oxide of size 160 90 nm duced less cell mortality compared with 780 410 nm at the ame concentration of 200 mg/ml. However, larger size does not lways cause less cytotoxicity. Akhavan and collaborators indicatd that, in human MSC, rGO nanoplatelets with smaller lateral imensions (11 4 nm) showed higher cytotoxicity than those ith larger lateral dimensions (3.8 0.4 mm) [177]. These contraictory observations could be explained by different interactions\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\n2 www.drugdiscoverytoday.com\nbetween cells and particles with different sizes, because Yan et al. demonstrated that small nanosheets entered cells mainly via clathrin-mediated endocytosis, while the increase in graphene size enhanced the phagocytotic uptake of the nanosheets [187].\nImpurities from the preparation process of GO could affect its biocompatibility. Kostarelos and co-workers reported that purified GO had negligible negative effects in vitro and in vivo compared with as-synthesized GO [188]. Therefore, it is necessary to conduct careful biological effects studies of these impurities.\nIn addition to in vitro studies, experiments were also performed in vivo to investigate graphene toxicity, which demonstrates more complexity when animal models are used. Typically, after intravenous injection, graphene materials were found in spleen, liver, and lung. However, Liu et al. reported that intraperitoneal injection of PEGylated graphene resulted in accumulation in spleen and liver, instead of lung [189]. By contrast, when graphene materials are administered via inhalation, they typically accumulate in the lung and often induce inflammation [190]. Intraocular administration of GO was studied in rabbits, and showed little effect on eyeball appearance, intraocular pressure eyesight, or histology sections [191]. Dash and collaborators reported that intravenous administration of GO induced extensive pulmonary thromboembolism in mice [192], whereas fewer effects were observed for rGO in the same study. Contradictory results were also observed in in vivo experiments, because GO was found to induce high hemolytic activity [193], which was inconsistent with the results of Wang et al. who reported that intravenous injection of GO at 0.1 mg and 0.25 mg showed no obvious toxicity [194]. Thus, we are still some way from completely understanding the toxicity of graphene-based materials."
    }, {
      "heading" : "Concluding remarks",
      "text" : "Here, we have reviewed the biomedical applications of graphenebased nanomaterials, including drug and/or gene delivery, bioimaging, and tissue engineering. Different types of graphene, its derivatives and composites have been introduced, and their properties related to biomedical applications have been discussed. The outstanding properties, such as a large specific surface area, excellent mechanical strength, and unique optical properties, of graphene-based materials, make them ideal candidates to load various drugs or genes for delivery, to act as imaging agents, as well as to enhance the mechanical properties of biomaterials for tissue engineering. Examples of these versatile applications have been presented here. Finally, we have also discussed the potential toxicity of these materials, even though the detailed toxic mechanisms remain uncertain or contradictory. Overall, we believe that graphene-based materials will open a new biomedical era. However, more efforts are required to completely elucidate the toxic principle of these materials before they can progress to clinical trials.\neferences\nNovoselov, K.S. et al. (2004) Electric field effect in atomically thin carbon films. Science 306, 666–669 Novoselov, K.S. et al. (2005) Two-dimensional atomic crystals. Proc. Natl. Acad. Sci. U. S. A. 102, 10451–10453 Geim, A.K. (2009) Graphene: status and prospects. Science 324, 1530–1534\n4 Geim, A.K. and Novoselov, K.S. (2007) The rise of graphene. Nat. Mater. 6, 183–191 5 Kuila, T. et al. (2013) Recent advances in the efficient reduction of graphene oxide\nand its application as energy storage electrode materials. Nanoscale 5, 52–71\n6 Tozzini, V. and Pellegrini, V. (2013) Prospects for hydrogen storage in graphene. Phys.\nChem. Chem. Phys. 15, 80–89\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\n7 Drug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\n7 Pumera, M. (2011) Graphene in biosensing. Mater. Today 14, 308–315 8 Kuila, T. et al. (2011) Recent advances in graphene-based biosensors. Biosens.\nBioelectron. 26, 4637–4648\n9 Zhang, K. et al. (2010) Graphene-polyaniline nanofiber composites as supercapacitor\nelectrodes. Chem. Mater. 22, 1392–1401\n10 Rao, C.N. et al. (2009) Graphene: the new two-dimensional nanomaterial. Angew.\nChem. Int. Ed. 48, 7752–7777\n11 Balandin, A.A. et al. (2008) Superior thermal conductivity of single-layer graphene.\nNano Lett. 8, 902–907\n12 Latil, S. and Henrard, L. (2006) Charge carriers in few-layer graphene films. Phys. Rev.\nLett. 97, 036803\n13 Chen, D. et al. (2010) Graphene-based materials in electrochemistry. Chem. Soc. Rev.\n39, 3157–3180\n14 Stoller, M.D. et al. (2008) Graphene-based ultracapacitors. Nano Lett. 8, 3498–3502 15 Lee, C. et al. (2008) Measurement of the elastic properties and intrinsic strength of\nmonolayer graphene. Science 321, 385–388\n16 Bolotin, K.I. et al. (2008) Ultrahigh electron mobility in suspended graphene. Solid\nState Commun. 146, 351–355\n17 Morozov, S.V. et al. (2008) Giant intrinsic carrier mobilities in graphene and its\nbilayer. Phys. Rev. Lett. 100, 016602\n18 Liu, Z. et al. (2008) PEGylated nanographene oxide for delivery of water-insoluble\ncancer drugs. J. Am. Chem. Soc. 130, 10876–10877\n19 Yang, W.R. et al. (2010) Carbon nanomaterials in biosensors: should you use\nnanotubes or graphene? Angew. Chem. Int. Ed. 49, 2114–2138\n20 Allen, M.J. et al. (2010) Honeycomb carbon: a review of graphene. Chem. Rev. 110,\n132–145\n21 Compton, O.C. and Nguyen, S.T. (2010) Graphene oxide, highly reduced graphene\noxide, and graphene: versatile building blocks for carbon-based materials. Small 6, 711–723 22 Yoo, J.M. (2015) Graphene-based nanomaterials for versatile imaging studies. Chem.\nSoc. Rev. 44, 4835–4852\n23 Goenka, S. et al. (2014) Graphene-based nanomaterials for drug delivery and tissue\nengineering. J. Control. Release 173, 75–88\n24 Hummers, W.S. and Offeman, R.E. (1958) Preparation of graphitic oxide. J. Am.\nChem. Soc. 80 1339–1339\n25 Cote, L.J. et al. (2009) Langmuir-blodgett assembly of graphite oxide single layers. J.\nAm. Chem. Soc. 131, 1043–1049\n26 Chen, D. et al. (2012) Graphene oxide: preparation, functionalization, and\nelectrochemical applications. Chem. Rev. 112, 6027–6053\n27 Eda, G. and Chhowalla, M. (2010) Chemically derived graphene oxide: towards\nlarge-area thin-film electronics and optoelectronics. Adv. Mater. 22, 2392–2415\n28 Li, X. et al. (2008) Highly conducting graphene sheets and Langmuir-Blodgett films.\nNat. Nanotechnol. 3, 538–542\n29 Lerf, A. et al. (1998) Structure of graphite oxide revisited. J. Phys. Chem. B 102, 4477–\n4482\n30 Paredes, J.I. et al. (2008) Graphene oxide dispersions in organic solvents. Langmuir\n24, 10560–10564\n31 Nurunnabi, M. et al. (2015) Bioapplication of graphene oxide derivatives: drug/gene\ndelivery, imaging, polymeric modification, toxicology, therapeutics and challenges. RSC Adv. 5, 42141–42161\n32 Xu, C. et al. (2015) Fabrication and characteristics of reduced graphene oxide\nproduced with different green reductants. PLoS One 10, e0144842\n33 Tung, V.C. et al. (2009) High-throughput solution processing of large-scale\ngraphene. Nat. Nanotechnol. 4, 25–29\n34 Chua, C.K. and Pumera, M. (2016) The reduction of graphene oxide with hydrazine:\nelucidating its reductive capability based on a reaction-model approach. Chem. Commun. 52, 72–75 35 Abdolhosseinzadeh, S. et al. (2015) Fast and fully-scalable synthesis of reduced\ngraphene oxide. Sci. Rep. 5, 10160\n36 Zhang, J. et al. (2010) Reduction of graphene oxide vial-ascorbic acid. Chem.\nCommun. 46, 1112–1114\n37 Shin, H.-J. et al. (2009) Efficient reduction of graphite oxide by sodium borohydride\nand its effect on electrical conductance. Adv. Funct. Mater. 19, 1987–1992\n38 Chua, C.K. and Pumera, M. (2013) Reduction of graphene oxide with substituted\nborohydrides. J. Mater. Chem. A 1, 1892–1898\n39 Wang, G. et al. (2008) Facile synthesis and characterization of graphene nanosheets.\nJ. Phys. Chem. C 112, 8192–8195\n40 Bourlinos, A.B. et al. (2003) Graphite oxide: chemical reduction to graphite and\nsurface modification with primary aliphatic amines and amino acids. Langmuir 19, 6050–6055\n41 Song, P. et al. (2012) Synthesis of graphene nanosheetsviaoxalic acid-induced\nchemical reduction of exfoliated graphite oxide. RSC Adv. 2, 1168–1173\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\n42 Fernández-Merino, M.J. et al. (2010) Vitamin C is an ideal substitute for hydrazine in\nthe reduction of graphene oxide suspensions. J. Phys. Chem. C 114, 6426–6432\n43 Dreyer, D.R. et al. (2011) Reduction of graphite oxide using alcohols. J. Mater. Chem.\n21, 3443–3447\n44 Bo, Z. et al. (2014) Green preparation of reduced graphene oxide for sensing and\nenergy storage applications. Sci. Rep. 4, 4684\n45 Lin, X. et al. (2012) Fabrication of highly-aligned, conductive, and strong graphene\npapers using ultralarge graphene oxide sheets. ACS Nano 6, 10708–10719\n46 Zhao, J. et al. (2010) Efficient preparation of large-area graphene oxide sheets for\ntransparent conductive films. ACS Nano 4, 5245–5252\n47 Bai, H. et al. (2009) Non-covalent functionalization Qof graphene sheets by sulfonated polyaniline. Chem. Commun. XX, 1667–1669 48 Zu, S.-Z. and Han, B.-H. (2009) Aqueous dispersion of graphene sheets stabilized by\npluronic copolymers: formation of supramolecular hydrogel. J. Phys. Chem. C 113, 13651–13657 49 Hao, R. et al. (2008) Aqueous dispersions of TCNQ-anion-stabilized graphene sheets.\nChem. Commun. XX, 6576–6578\n50 Xu, Y. et al. (2008) Flexible graphene films via the filtration of water-soluble\nnoncovalent functionalized graphene sheets. J. Am. Chem. Soc. 130, 5856–5857\n51 Jin, L. et al. (2016) Fabrication, characterization, and biocompatibility of polymer\ncored reduced graphene oxide nanofibers. ACS Appl. Mater Interfaces 8, 5170–5177 52 Cardenas, L. et al. (2014) Reduced graphene oxide growth on 316L stainless steel for\nmedical applications. Nanoscale 6, 8664–8670\n53 Zhang, X.-F. and Gurunathan, S. (2016) Biofabrication of a novel biomolecule-\nassisted reduced graphene oxide: an excellent biocompatible nanomaterial. Int. J. Nanomed. 11, 15\n54 Tang, L. et al. (2012) Deep ultraviolet photoluminescence of water-soluble self-\npassivated graphene quantum dots. ACS Nano 6, 5102–5110\n55 Liu, R. et al. (2011) Bottom-up fabrication of photoluminescent graphene quantum\ndots with uniform morphology. J. Am. Chem. Soc. 133, 15221–15223\n56 Pan, D. et al. (2010) Hydrothermal route for cutting graphene sheets into blue-\nluminescent graphene quantum dots. Adv. Mater. 22, 734–738\n57 Qu, D. et al. (2014) Formation mechanism and optimization of highly luminescent\nN-doped graphene quantum dots. Sci. Rep. 4, 5294\n58 Peng, J. et al. (2012) Graphene quantum dots derived from carbon fibers. Nano Lett.\n12, 844–849\n59 Favaro, M. et al. (2015) Single and multiple doping in graphene quantum dots:\nunraveling the origin of selectivity in the oxygen reduction reaction. ACS Catal. 5, 129–144 60 Schnez, S. et al. (2009) Observation of excited states in a graphene quantum dot.\nAppl. Phys. Lett. 94, 012107\n61 Yan, X. et al. (2010) Synthesis of large, stable colloidal graphene quantum dots with\ntunable size. J. Am. Chem. Soc. 132, 5944–5945\n62 Lu, J. et al. (2011) Transforming C60 molecules into graphene quantum dots. Nat.\nNanotechnol. 6, 247–252\n63 Wang, L. et al. (2014) Gram-scale synthesis of single-crystalline graphene quantum\ndots with superior optical properties. Nat. Commun. 5, 5357\n64 Guo, C.X. et al. (2010) Layered graphene/quantum dots for photovoltaic devices.\nAngew. Chem. Int. Ed. 49, 3014–3017\n65 Girit, Ç .Ö. et al. (2009) Graphene at the edge: stability and dynamics. Science 323,\n1705–1708\n66 Gupta, V. et al. (2011) Luminescent graphene quantum dots for organic\nphotovoltaic devices. J. Am. Chem. Soc. 133, 9960–9963\n67 Shtein, M. et al. (2015) Characterization of graphene-nanoplatelets structure via\nthermogravimetry. Anal. Chem. 87, 4076–4080\n68 Li, L. et al. (2013) Focusing on luminescent graphene quantum dots: current status\nand future perspectives. Nanoscale 5, 4015–4039\n69 Buzaglo, M. et al. (2016) Graphene quantum dots produced by microfluidization.\nChem. Mater. 28, 21–24\n70 Yang, S.-T. et al. (2009) Carbon dots for optical imaging in vivo. J. Am. Chem. Soc. 131,\n11308–11309\n71 Baker, S.N. and Baker, G.A. (2010) Luminescent carbon nanodots: emergent\nnanolights. Angew. Chem. Int. Ed. 49, 6726–6744\n72 Ran, X. et al. (2013) Ag nanoparticle-decorated graphene quantum dots for label-\nfree, rapid and sensitive detection of Ag+ and biothiols. Chem. Commun. 49, 1079– 1081 73 Sun, H. et al. (2015) Synthesis of fluorinated and nonfluorinated graphene quantum\ndots through a new top-down strategy for long-time cellular imaging. Chem. Eur. J. 21, 3791–3797\n74 Ge, J. et al. (2015) Red-emissive carbon dots for fluorescent, photoacoustic, and\nthermal theranostics in living Mice. Adv. Mater. 27, 4169–4177\n75 Ge, J. et al. (2014) A graphene quantum dot photodynamic therapy agent with high\nsinglet oxygen generation. Nat. Commun. 5, 4596\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nwww.drugdiscoverytoday.com 13\n7 7\n7\n7\n8\n8\n8\n8\n8\n8\n8\n8\n8\n8\n9\n9\n9\n9\n9\n9\n9\n9\n9\n9\n1\n1\n1\n1\n0\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\n1\nReview s K EY N O TE R EV IEW\n6 Zhang, Q. et al. (2014) Synthesis of amphiphilic reduced graphene oxide with an\nenhanced charge injection capacity for electrical stimulation of neural cells. J. Mater. Chem. B 2, 4331–4337\n7 Chen, W. et al. (2015) Assembly of Fe3O4 nanoparticles on PEG-functionalized\ngraphene oxide for efficient magnetic imaging and drug delivery. RSC Adv. 5, 69307–69311\n8 Shi, S. et al. (2014) Surface engineering of graphene-based nanomaterials for\nbiomedical applications. Bioconjugate Chem. 25, 1609–1619\n9 Zhang, C. et al. (2016) Co-delivery of paclitaxel and indocyanine green by PEGylated\ngraphene oxide: a potential integrated nanoplatform for tumor theranostics. RSC Adv. 6, 15460–15468 0 Jin, R. et al. (2013) Self-assembled graphene-dextran nanohybrid for killing drug-\nresistant cancer cells. ACS Appl. Mater Interfaces 5, 7181–7189\n1 Lee, Y. et al. (2015) Injectable and mechanically robust 4-arm PPO-PEO/graphene\noxide composite hydrogels for biomedical applications. Chem. Commun. 51, 8876–8879\n2 Deshmukh, K. et al. (2016) Graphene oxide reinforced polyvinyl alcohol/\npolyethylene glycol blend composites as high-performance dielectric material. J. Polym. Res. 23, 159 3 Teimouri, M. et al. (2016) Graphene oxide-cationic polymer conjugates synthesis\nand application as gene delivery vectors. Plasmid 84–85, 51–60\n4 Choi, H.Y. et al. (2016) Efficient mRNA delivery with graphene oxide-\npolyethylenimine for generation of footprint-free human induced pluripotent stem cells. J. Control. Release 235, 222–235\n5 Cao, X. et al. (2015) Functionalized graphene oxide with hepatocyte targeting as\nanti-tumor drug and gene intracellular transporters. J. Nanosci. Nanotechnol. 15, 2052–2059\n6 Hu, H. et al. (2014) Folate conjugated trimethyl chitosan graphene oxide\nnanocomplexes as potential carriers for drug and gene delivery. Mater. Lett. 125, 82– 85 7 Wu, S. et al. (2015) High concentration and stable aqueous dispersion of graphene\nstabilized by a new amphiphilic copolymer Fullerene, Nanotubes. Carbon Nanostruct. 23, 974–984\n8 Solanki, A. et al. (2013) Axonal alignment and enhanced neuronal differentiation of\nneural stem cells on graphene-nanoparticle hybrid structures. Adv. Mater. 25, 5477– 5482\n9 Zhou, X. et al. (2014) A quantitative study of the intracellular concentration of\ngraphenenoble metal nanocomposites and their cytotoxicity. Nanoscale 6, 8535–8542\n0 Chen, H. et al. (2015) Fe2O3@Au core@shell nanoparticle-graphene\nnanocomposites as theranostic agents for bioimaging and chemo-photothermal synergistic therapy. RSC Adv. 5, 84980–84987\n1 Peng, E. et al. (2012) Synthesis of manganese ferrite/graphene oxide\nnanocomposites for biomedical applications. Small 8, 3620–3630\n2 Dinda, S. et al. (2016) Grafting of ZnS:Mn-doped nanocrystals and an anticancer\ndrug onto graphene oxide for delivery and cell labeling. ChemPlusChem 81, 100–107\n3 Lee, J.H. et al. (2015) Reduced graphene oxide-coated hydroxyapatite composites\nstimulate spontaneous osteogenic differentiation of human mesenchymal stem cells. Nanoscale 7, 11642–11651\n4 Lee, W.C. et al. (2015) Cell-assembled graphene biocomposite for enhanced\nchondrogenic differentiation. Small 11, 963–969\n5 Gao, W. et al. (2009) New insights into the structure and reduction of graphite\noxide. Nat. Chem. 1, 403–408\n6 Zhu, Y. et al. (2010) Graphene and graphene oxide: synthesis, properties, and\napplications. Adv. Mater. 22, 3906–3924\n7 Soldano, C. et al. (2010) Production, properties and potential of graphene. Carbon\n48, 2127–2150\n8 Loh, K.P. et al. (2010) The chemistry of graphene. J. Mater. Chem. 20,\n2277–2289\n9 Viswanathan, S. et al. (2015) Graphene-protein field effect biosensors: glucose\nsensing. Mater. Today 18, 513–522\n00 Georgakilas, V. et al. (2016) Noncovalent functionalization of graphene and\ngraphene oxide for energy materials, biosensing, catalytic, and biomedical applications. Chem. Rev. 116, 5464–5519\n01 Sun, X. et al. (2008) Nano-graphene oxide for cellular imaging and drug delivery.\nNano Res. 1, 203–212\n02 Zhang, L. et al. (2011) Enhanced chemotherapy efficacy by sequential delivery\nof siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7, 460–464\n03 Zhang, L. et al. (2010) Functional graphene oxide as a nanocarrier for controlled\nloading and targeted delivery of mixed anticancer drugs. Small 6, 537–544\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\n4 www.drugdiscoverytoday.com\n104 Wang, H. et al. (2015) Enhanced mechanical properties of multi-layer graphene\nfilled poly(vinyl chloride) composite films. J. Mater. Sci. Technol. 31, 340–344\n105 Das, B. et al. (2009) Nano-indentation studies Q8on polymer matrix composites reinforced by few-layer graphene. Nanotechnology 20 125705 106 Cohen-Karni, T. et al. (2010) Graphene and nanowire transistors for cellular\ninterfaces and electrical recording. Nano Lett. 10, 1098–1102\n107 He, Q. et al. (2010) Centimeter-long and large-scale micropatterns of reduced\ngraphene oxide films: fabrication and sensing applications. ACS Nano 4, 3201–3208\n108 Li, N. et al. (2013) Three-dimensional graphene foam as a biocompatible and\nconductive scaffold for neural stem cells. Sci. Rep. 3, 1604\n109 Stankovich, S. et al. (2006) Stable aqueous dispersions of graphitic nanoplatelets\nvia the reduction of exfoliated graphite oxide in the presence of poly(sodium 4-styrenesulfonate). J. Mater. Chem. 16, 155–158\n110 Nair, R.R. et al. (2008) Fine structure constant defines visual transparency of\ngraphene. Science 320 1308–1308\n111 Kravets, V.G. et al. (2010) Spectroscopic Q9ellipsometry of graphene and an excitonshifted van Hove peak in absorption. Phys. Rev. B 81 XXX–YYY 112 Zhu, S. et al. (2011) Strongly green-photoluminescent graphene quantum dots for\nbioimaging applications. Chem. Commun. 47, 6858–6860\n113 Sun, X. et al. (2016) A graphene oxide-based FRET sensor for rapid and specific\ndetection of unfolded collagen fragments. Biosens. Bioelectron. 79, 15–21\n114 Zhang, M. et al. (2011) Interaction of peptides with graphene oxide and its\napplication for real-time monitoring of protease activity. Chem. Commun. 47, 2399–2401\n115 Wang, H. et al. (2011) Graphene oxide-peptide conjugate as an intracellular\nprotease sensor for caspase-3 activation imaging in live cells. Angew. Chem. Int. Ed. 50, 7065–7069\n116 Li, M. et al. (2012) Using graphene oxide high near-infrared absorbance for\nphotothermal treatment of Alzheimer’s disease. Adv. Mater. 24, 1722–1728\n117 Zhou, K. et al. (2010) One-pot preparation of graphene/Fe3O4 composites by a\nsolvothermal reaction. New J. Chem. 34, 2950\n118 Xu, Z. et al. (2014) Covalent functionalization of graphene oxide with\nbiocompatible poly(ethylene glycol) for delivery of paclitaxel. ACS Appl. Mater Interfaces 6, 17268–17276\n119 Angelopoulou, A. et al. (2015) Graphene oxide stabilized by PLA-PEG\ncopolymers for the controlled delivery of paclitaxel. Eur. J. Pharm. Biopharm. 93, 18–26\n120 Yang, Z.R. et al. (2007) Recent developments in the use of adenoviruses and\nimmunotoxins in cancer gene therapy. Cancer Gene Ther. 14, 599–615\n121 Liu, X. et al. (2014) Polyamidoamine dendrimer and oleic acid-functionalized\ngraphene as biocompatible and efficient gene delivery vectors. ACS Appl. Mater Interfaces 6, 8173–8183\n122 Tian, B. et al. (2011) Photothermally enhanced photodynamic therapy delivered\nby nano-graphene oxide. ACS Nano 5, 7000–7009\n123 Feng, L. et al. (2011) Graphene based gene transfection. Nanoscale 3, 1252–1257 124 Yang, H.-W. et al. (2014) Gadolinium-functionalized nanographene oxide for\ncombined drug and microRNA delivery and magnetic resonance imaging. Nano Res. 12274\n125 Sun, Y. et al. (2016) Fabrication of mPEGylated graphene oxide/poly(2-\ndimethylaminoethyl methacrylate) nanohybrids and their primary application Q1for small interfering RNA delivery. J. Appl. Polym. Sci. XX, 43303\n126 Shen, H. et al. (2012) PEGylated graphene oxide-mediated protein delivery for cell\nfunction regulation. ACS Appl. Mater Interfaces 4, 6317–6323\n127 Choi, M. et al. (2015) Multilayered graphene nano-film for controlled protein\ndelivery by desired electro-stimuli. Sci. Rep. 5, 17631\n128 La, W.-G. et al. (2013) Delivery of a therapeutic protein for bone regeneration from\na substrate coated with graphene oxide. Small 9, 4051–4060\n129 Li, H. et al. (2016) Spontaneous protein adsorption on graphene oxide nanosheets\nallowing efficient intracellular vaccine protein delivery. ACS Appl. Mater Interfaces 8, 1147–1155 130 Janib, S.M. et al. (2010) Imaging and drug delivery using theranostic nanoparticles.\nAdv. Drug Delivery Rev. 62, 1052–1063\n131 Lin, J. et al. (2016) Graphene-based nanomaterials for bioimaging. Adv. Drug\nDelivery Rev. 105, 242–254\n132 Yang, K. et al. (2013) Nano-graphene in biomedicine: theranostic applications.\nChem. Soc. Rev. 42, 530–547\n133 Yang, K. et al. (2010) Graphene in mice: ultrahigh in vivo tumor uptake and\nefficient photothermal therapy. Nano Lett. 10, 3318–3323\n134 Sun, Z. et al. (2013) VEGF-loaded graphene oxide as theranostics for multi-\nmodality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. Nanoscale 5, 6857–6866\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nQ11\n12\n13\nDrug Discovery Today Volume 00, Number 00 September 2017 REVIEWS\nRe vi ew\ns K\nEY N O TE\nR EV\nIE W\n135 Yan, X. et al. (2015) Enhanced fluorescence imaging guided photodynamic\ntherapy of sinoporphyrin sodium loaded graphene oxide. Biomaterials 42, 94–102\n136 Shen, J. et al. (2011) Facile preparation and upconversion luminescence of\ngraphene quantum dots. Chem. Commun. 47, 2580–2582\n137 Dong, H. et al. (2015) Multifunctional poly(L-lactide)-polyethylene glycol-grafted\ngraphene quantum dots for intracellular microRNA imaging and combined specific-gene-targeting agents delivery for improved therapeutics. ACS Appl. Mater Interfaces 7, 11015–11023\n138 Wen, T. et al. (2014) Organosilane-functionalized graphene quantum dots and\ntheir encapsulation into bi-layer hollow silica spheres for bioimaging applications. Phys. Chem. Chem. Phys. 16, 23188–23195 139 Li, J. et al. (2015) Highly sensitive transient absorption imaging of graphene and\ngraphene oxide in living cells and circulating blood. Sci. Rep. 5, 12394\n140 Song, Z.-L. et al. (2014) Alkyne-functionalized superstable graphitic silver\nnanoparticles for Raman imaging. J. Am. Chem. Soc. 136, 13558–13561\n141 Liu, Z. et al. (2013) Graphene oxide based surface-enhanced Raman scattering\nprobes for cancer cell imaging. Phys. Chem. Chem. Phys. 15, 2961–2966\n142 Ma, X. et al. (2013) Graphene oxide wrapped gold nanoparticles for intracellular\nRaman imaging and drug delivery. J. Mater. Chem. B 1, 6495–6500\n143 Wang, Y. et al. (2014) Reduced graphene oxide-supported gold nanostars for\nimproved SERS sensing and drug delivery. ACS Appl. Mater Interfaces 6, 21798– 21805\n144 Huang, J. et al. (2012) Mechanism of cellular uptake of graphene oxide studied by\nsurface-enhanced Raman spectroscopy. Small 8, 2577–2584\n145 Nie, L. and Chen, X. (2014) Structural and functional photoacoustic molecular\ntomography aided by emerging contrast agents. Chem. Soc. Rev. 43, 7132–7170\n146 Kanakia, S. et al. (2015) Towards an advanced graphene-based magnetic resonance\nimaging contrast agent: sub-acute toxicity and efficacy studies in small animals. Sci. Rep. 5, 17182 147 Sun, B. et al. (2017) In situ synthesis of graphene oxide/gold nanorods theranostic\nhybrids for efficient tumor computed tomography imaging and photothermal therapy. Nano Res. 10, 37–48 148 Shi, S. et al. (2017) Chelator-free radiolabeling of nanographene: breaking the\nstereotype of chelation. Angew. Chem. Int. Ed. in press\n149 Fazaeli, Y. et al. (2014) In vivo SPECT imaging of tumors by 198,199Au-labeled\ngraphene oxide nanostructures. Mater. Sci. Eng. C 45, 196–204\n150 Langer, R. and Vacanti, J. (1993) Tissue engineering. Science 260, 920–926 151 Shin, S.R. et al. (2013) Cell-laden microengineered and mechanically tunable\nhybrid hydrogels of gelatin and graphene oxide. Adv. Mater. 25, 6385–6391\n152 Cha, C. et al. (2014) Controlling mechanical properties of cell-laden hydrogels by\ncovalent incorporation of graphene oxide. Small 10, 514–523\n153 Xie, X. et al. (2015) Graphene and hydroxyapatite self-assemble into\nhomogeneous, free standing nanocomposite hydrogels for bone tissue engineering. Nanoscale 7, 7992–8002\n154 Faghihi, S. et al. (2014) Graphene oxide/poly(acrylic acid)/gelatin nanocomposite\nhydrogel: experimental and numerical validation of hyperelastic model. Mater. Sci. Eng. C 38, 299–305\n155 Depan, D. et al. (2011) Structure-process-property relationship of the polar\ngraphene oxide-mediated cellular response and stimulated growth of osteoblasts on hybrid chitosan network structure nanocomposite scaffolds. Acta Biomater. 7, 3432–3445\n156 Park, S. et al. (2010) Biocompatible, robust free-standing paper composed of a\nTWEEN/graphene composite. Adv. Mater. 22, 1736–1740\n157 Lu, B. et al. (2012) Graphene-based composite materials beneficial to wound\nhealing. Nanoscale 4, 2978–2982\n158 Park, S.Y. et al. (2011) Enhanced differentiation of human neural stem cells into\nneurons on graphene. Adv. Mater. 23 (36), H263–H267\n159 Li, N. et al. (2011) The promotion of neurite sprouting and outgrowth of\nmouse hippocampal cells in culture by graphene substrates. Biomaterials 32, 9374– 9382\n160 Yang, K. et al. (2013) Behavior and toxicity of graphene and its functionalized\nderivatives in biological systems. Small 9, 1492–1503\n161 Guo, W. et al. (2016) Self-powered electrical stimulation for enhancing neural\ndifferentiation of mesenchymal stem cells on graphene-poly(3,4ethylenedioxythiophene) hybrid microfibers. ACS Nano 10, 5086–5095\n162 Lee, W.C. et al. (2011) Origin of enhanced stem cell growth and differentiation on\ngraphene and graphene oxide. ACS Nano 5, 7334–7341\n163 Guo, M. et al. (2013) N-containing functional groups induced superior\ncytocompatible and hemocompatible graphene by NH2 ion implantation. J. Mater. Sci. Mater. Med. 24, 2741–2748\n164 Krueger, E. et al. (2016) Graphene foam as a three-dimensional platform for\nmyotube growth. ACS Biomater. Sci. Eng. 2, 1234–1241\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for drug a dx.doi.org/10.1016/j.drudis.2017.04.002\n165 Ku, S.H. and Park, C.B. (2013) Myoblast differentiation on graphene oxide.\nBiomaterials 34, 2017–2023\n166 Yoon, H.H. et al. (2014) Dual roles of graphene oxide in chondrogenic\ndifferentiation of adult stem cells: cell-adhesion substrate and growth factordelivery carrier. Adv. Funct. Mater. 24, 6455–6464\n167 Liu, H. et al. (2014) Gelatin functionalized graphene oxide for mineralization of\nhydroxyapatite: biomimetic and in vitro evaluation. Nanoscale 6, 5315–5322\n168 Liu, H. et al. (2014) Biomimetic and cell-mediated mineralization of\nhydroxyapatite by carrageenan functionalized graphene oxide. ACS Appl. Mater Interfaces 6, 3132–3140 169 Podila, R. et al. (2013) Graphene coatings for enhanced hemo-compatibility of\nnitinol stents. RSC Adv. 3, 1660–1665\n170 Podila, R. et al. (2013) Graphene coatings for biomedical implants. Journal QTitle XX, e50276 171 Zhang, W. et al. (2014) Use of graphene as protection film in biological\nenvironments. Sci. Rep. 4, 4097\n172 Li, M. et al. (2014) Graphene oxide/hydroxyapatite composite coatings fabricated\nby electrophoretic nanotechnology for biological applications. Carbon 67, 185– 197\n173 Bianco, A. (2013) Graphene: safe or toxic? The two faces of the medal. Angew.\nChem. Int. Ed. 52, 4986–4997\n174 Hu, W. et al. (2010) Graphene-based antibacterial paper. ACS Nano 4, 4317–4323 175 Zhang, Y. et al. (2010) Cytotoxicity effects of graphene and single-wall carbon\nnanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 4, 3181– 3186\n176 Akhavan, O. et al. (2013) Genotoxicity of graphene nanoribbons in human\nmesenchymal stem cells. Carbon 54, 419–431\n177 Akhavan, O. et al. (2012) Size-dependent genotoxicity of graphene nanoplatelets\nin human stem cells. Biomaterials 33, 8017–8025\n178 Vallabani, N.V.S. et al. (2011) Toxicity of graphene in normal human lung cells\n(BEAS-2B). J. Biomed. Nanotechnol. 7, 106–107\n179 Liu, S. et al. (2012) Lateral dimension-dependent antibacterial activity of graphene\noxide sheets. Langmuir 28, 12364–12372\n180 Chang, Y. et al. (2011) In vitro toxicity evaluation of graphene oxide on A549 cells.\nToxicol. Lett. 200, 201–210\n181 Jaworski, S. et al. (2013) In vitro evaluation of the effects of graphene platelets on\nglioblastoma multiforme cells. Int. J. Nanomed. 8, 413–420\n182 Moore, T.L. et al. (2014) Systemic administration of polymer-coated nano-\ngraphene to deliver drugs to glioblastoma. Part. Part. Syst. Charact. 31, 886–894\n183 Corr, S.J. et al. (2013) Cytotoxicity and variant cellular internalization behavior of\nwater-soluble sulfonated nanographene sheets in liver cancer cells. Nanoscale Res. Lett. 8, 208 184 Sasidharan, A. et al. (2011) Differential nano-bio interactions and toxicity effects of\npristine versus functionalized graphene. Nanoscale 3, 2461–2464\n185 Zhang, S.A. et al. (2011) In vitro and in vivo behaviors of dextran functionalized\ngraphene. Carbon 49, 4040–4049\n186 Chowdhury, S.M. et al. (2013) In vitro hematological Qand in vivo vasoactivity assessment of dextran functionalized graphene. Sci. Rep. 3 XXXX 187 Mu, Q. et al. (2012) Size-dependent cell uptake of protein-coated graphene oxide\nnanosheets. ACS Appl. Mater Interfaces 4, 2259–2266\n188 Ali-Boucetta, H. et al. (2013) Purified graphene oxide dispersions lack in vitro\ncytotoxicity and in vivo pathogenicity. Adv. Healthcare Mater. 2, 433–441\n189 Yang, K. et al. (2011) In vivo pharmacokinetics, long-term biodistribution, and\ntoxicology of PEGylated graphene in mice. ACS Nano 5, 516–522\n190 Duch, M.C. et al. (2011) Minimizing oxidation and stable nanoscale dispersion\nimproves the biocompatibility of graphene in the lung. Nano Lett. 11, 5201–5207\n191 Yan, L. et al. (2012) Can graphene oxide cause damage to eyesight? Chem. Res.\nToxicol. 25, 1265–1270\n192 Singh, S.K. et al. (2011) Thrombus inducing property of atomically thin graphene\noxide sheets. ACS Nano 5, 4987–4996\n193 Liao, K.-H. et al. (2011) Cytotoxicity of graphene oxide and graphene in human\nerythrocytes and skin fibroblasts. ACS Appl. Mater Interfaces 3, 2607–2615\n194 Wang, K. et al. (2011) Biocompatibility of graphene oxide. Nanoscale Res. Lett. 6, 8 195 Yang, X. et al. (2014) Biocleavable graphene oxide based-nanohybrids synthesized\nvia ATRP for gene/drug delivery. Nanoscale 6, 6141–6150\n196 Patel, P.R.B. et al. (2016) Composite system of graphene oxide and polypeptide\nthermogel as an injectable 3D scaffold for adipogenic differentiation of tonsilderived mesenchymal stem cells. ACS Appl. Mater Interfaces 8, 5160–5169\n197 Imani, R. et al. (2015) Synthesis and characterization of an octaarginine\nfunctionalized graphene oxide nano-carrier for gene delivery applications. Phys. Chem. Chem. Phys. 17, 6328–6339\nnd/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://\nwww.drugdiscoverytoday.com 15\n1 1\n2\nREVIEWS Drug Discovery Today Volume 00, Number 00 September 2017\n1\nReview s K EY N O TE R EV IEW\n98 Zeng, Y. et al. (2015) Fast and facile preparation of PEGylated graphene from\ngraphene oxide by lysosome targeting delivery of photosensitizer to efficiently enhance photodynamic therapy. RSC Adv. 5, 57725–57734\n99 Tian, L. et al. (2014) Functionalized nanoscale graphene oxide for high efficient\ndrug delivery of cisplatin. J. Nanopart. Res. 16, 2709\n00 Pan, Y. et al. (2011) Water-soluble poly(N-isopropylacrylamide)-graphene sheets\nsynthesized via click chemistry for drug delivery. Adv. Funct. Mater. 21, 2754–2763\nPlease cite this article in press as: D.O.C.Zhao, D.O.C. Graphene-based nanomaterials for dru dx.doi.org/10.1016/j.drudis.2017.04.002\n6 www.drugdiscoverytoday.com\n201 Rana, V.K. et al. (2011) Synthesis and drug-delivery behavior of chitosan-\nfunctionalized graphene oxide hybrid nanosheets. Macromol. Mater. Eng. 296, 131–140 202 Fan, X. et al. (2013) The preparation and drug delivery of a graphene-carbon\nnanotube-Fe3O4 nanoparticle hybrid. J. Mater. Chem. B 1, 2658–2664\n203 Zhou, L. et al. (2011) Graphene oxide noncovalent photosensitizer and its\nanticancer activity in vitro. Chem. Eur. J. 17, 12084–12091\ng and/or gene delivery, bioimaging, and tissue engineering, Drug Discov Today (2017), http://"
    } ],
    "references" : [ ],
    "referenceMentions" : [ ],
    "year" : 2017,
    "abstractText" : "1 John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA 2 Research Institute of Petroleum Processing, SINOPEC, Beijing 100083, China Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA 4 Interdisciplinary Division of Biomedical Engineering, the Hong Kong Polytechnic University, Hung Hom, Hong Kong Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA Barnet General Hospital Royal Free NHS Trust Hospital, Wellhouse Lane, Barnet EN5 3DJ, UK Department of Biomedical Engineering and Biotechnology, University of Massachusetts Lowell, Lowell, MA 01854, USA",
    "creator" : "Elsevier"
  }
}